Zbtb38 transcriptionally activates XIAP to regulate apoptosis in development and cancer
Journal of Molecular Cell Biology · 03.07.2026 · 18
DOI: 10.1093/jmcb/mjag011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 17.03.2026. Verfasst von Toshiaki Shigeoka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Functional Genomics and Medicine, Nara Institute of Science and Technology, Ikoma 630-0192, Japan. Hauptthemen laut MEDLINE: X-Linked Inhibitor of Apoptosis Protein, Apoptosis, Neoplasms, Repressor Proteins. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The X-linked inhibitor of apoptosis protein (XIAP) is a key suppressor of apoptosis, crucial for cellular differentiation, embryogenesis, and cancer progression. However, its upstream regulatory mechanisms remain poorly understood. Here, we demonstrate that the zinc finger transcription factor Zbtb38, a negative regulator of apoptosis, modulates XIAP expression in both loss- and gain-of-function experiments, irrespective of p53 expression. Notably, XIAP overexpression rescues the apoptosis induced by Zbtb38 knockdown, indicating that Zbtb38-associated apoptosis is at least partially XIAP-dependent. Mechanistically, Zbtb38 binds to E-box motifs within upstream regulatory regions of XIAP and activates its transcription. During embryonic stem cell differentiation and embryogenesis, Zbtb38 depletion increases apoptosis and reduces XIAP and Bcl-2 expression, underscoring their functional relevance in these processes. Analysis of human tumor datasets reveals a strong positive correlation between ZBTB38 and XIAP expression, with elevated ZBTB38 levels associated with high-grade malignancies. Furthermore, Zbtb38 knockdown induces apoptosis in cancer cells with reduced XIAP expression, regardless of p53 expression. Collectively, these findings uncover a novel Zbtb38–XIAP axis that regulates apoptosis during cellular differentiation, development, and oncogenesis and highlight its therapeutic potential in XIAP-driven and p53-deficient tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Functional Genomics and Medicine, Nara Institute of Science and Technology, Ikoma 630-0192, Japan.
- Faculty of Pharmacy, University of Muhammadiyah Purwokerto, Jalan Raya Dukuhwaluh PO BOX 202, Purwokerto 53052, Indonesia.
- Gene Regulation Research, Nara Institute of Science and Technology, Ikoma 630-0192, Japan.
ORCID-Profile: Yasumasa Ishida
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Shigeoka, T., Nagaoka, H., Nurulita, N. A., Tada, S., Bessho, Y., Ishida, Y., & Matsuda, E. (2026). Zbtb38 transcriptionally activates XIAP to regulate apoptosis in development and cancer. Journal of Molecular Cell Biology, 18. https://doi.org/10.1093/jmcb/mjag011
Vancouver
Shigeoka T, Nagaoka H, Nurulita NA, Tada S, Bessho Y, Ishida Y, et al. Zbtb38 transcriptionally activates XIAP to regulate apoptosis in development and cancer. Journal of Molecular Cell Biology. 2026;18. doi:10.1093/jmcb/mjag011
BibTeX
@article{Shigeoka2026,
author = {Shigeoka, Toshiaki and Nagaoka, Hiroyuki and Nurulita, Nunuk Aries and Tada, Shogo and Bessho, Yasumasa and Ishida, Yasumasa and Matsuda, Eishou},
title = {Zbtb38 transcriptionally activates XIAP to regulate apoptosis in development and cancer},
journal = {Journal of Molecular Cell Biology},
year = {2026},
volume = {18},
doi = {10.1093/jmcb/mjag011}
}
EUVIMED